Document Detail

Risk factors in the development of multiple sclerosis.
MedLine Citation:
PMID:  20477024     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Multiple sclerosis (MS) is a T-cell-mediated demyelinating disease of the CNS with no known cure or cause. However, it is widely believed that MS is caused by an environmental trigger(s) in genetically susceptible individuals. Several lines of evidence suggest that infection with Epstein-Barr virus and cigarette smoking increase the risk of MS, whereas vitamin D plays a protective role. This review discusses the current evidence supporting a link between these factors and MS.
Kassandra L Munger; Alberto Ascherio
Related Documents :
21735614 - Socioeconomic marriage differentials in australia and new zealand.
9094044 - Multiple sclerosis in the turkish- and greek-speaking communities of cyprus. a united n...
23512874 - The influence of neighbors' family size preference on progression to high parity births...
22147364 - Breast cancer screening trends in the united states and ethnicity.
23175734 - Electric shocks at work in europe: development of a job exposure matrix.
9744134 - Assessing the relationship between maternal opiate use and neonatal mortality.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of clinical immunology     Volume:  3     ISSN:  1744-8409     ISO Abbreviation:  Expert Rev Clin Immunol     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2010-05-18     Completed Date:  2010-06-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101271248     Medline TA:  Expert Rev Clin Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  739-48     Citation Subset:  -    
Harvard School of Public Health, Department of Nutrition, 655 Huntington Ave, Boston, MA 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical implication of autoantibodies in patients with systemic rheumatic diseases.
Next Document:  Preclinical models of multiple sclerosis in nonhuman primates.